Growth potential Mid-sized CRO with revenue in the 10–25M range and a long track record since 1974, indicating an opportunity to upsell larger-scale programs or expand into additional therapeutic areas and trial services.

Full-service strengths Offers end-to-end CRO capabilities including consulting, clinical operations, data management, and statistics, presenting a compelling cross-sell case for clients seeking a unified vendor and potential expansion into regulated submissions and post-market activities.

Regulatory track Over 90 regulatory approvals to date signals credibility with clients pursuing complex regulatory pathways, suggesting opportunities to win additional filings, device and pharmaceutical programs, or global submissions.

Tech backbone Technology stack featuring AWS, SAP, XML, and data-centric tools supports scalable operations; present SDTM/EDC integration or data management modernization services to optimize trial efficiency for current and prospective clients.

Talent momentum Recent leadership hire in data management and a lean 51–200 employee base point to growth and potential capacity expansion; target mid-market sponsors and growing biotech firms with increasing CRO needs and expanding trial portfolios.